openPR Logo
Press release

Neurosyphilis Market - Growth Drivers - Abbott, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc. , Novartis AG , Pfizer Inc.,Sanofi | Strategic Analysis 2023

10-01-2018 03:55 PM CET | Health & Medicine

Press release from: Market Research Future

Neurosyphilis Market - Growth Drivers - Abbott, Bayer AG, Eli

Market Research Future recently presented Global Neurosyphilis Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2023.

Global Neurosyphilis Market -Scenario

Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual who have untreated syphilis for long period of time.

This is mainly caused due to bacteria called Treponema pallidum. This is the bacteria which causes syphilis. After getting infected with syphilis for the first time, there are chances of neurosyphilis after 10-20 years later.

The major symptoms of neurosyphilis are blindness, abnormal walk, confusion, depression, dementia, headache, irritability, incontinence, poor concentration, numbness in the toes, feet, or legs, seizures, tremors, stiff neck, visual disturbances, and weakness.

There are possibility of no symptoms of neurosyphilis. Out of all types of neurosyphilis, asymptomatic neurosyphilis is the most common type.

Global Neurosyphilis Market -Key players                                       

Some of the key players in this market are:

Abbott (US)
Bayer AG (Germany)
Eli Lilly and Company (US)
GlaxoSmithKline plc. (UK)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Sanofi (France)

Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/4021

Considering the market scenario of global neurosyphilis, increasing funding for research, clinical trials, and new product development are driving the growth for the market. Government and companies are investing large amount of money to derive effective cure for neurosyphilis.

Adoption of technologically advanced diagnostic medical devices are another important driver for the market. Some other factors like increasing awareness, rising demand from emerging markets, government support to improve public healthcare, and changing healthcare practices are also major factors for the market growth.

The global neurosyphilis market is growing steadily and is expected to continue its growth during the forecast period. Global neurosyphilis market is expected to grow at the CAGR of ~3.9% during the forecast period and is estimated to reach USD 957.4 million by 2023.

Global Neurosyphilis Market -Segments 

Global neurosyphilis market has been segmented on the basis of type which comprise asymptomatic neurosyphilis, meningeal neurosyphilis, meningovascular neurosyphilis, general paresis, tabes dorsalis, and others.

Obtain Report Details with TOC @ https://www.marketresearchfuture.com/reports/neurosyphilis-market-4021

On the basis of diagnosis, the market is segmented into physical exam, blood test, spinal tap, imaging tests, and others. Blood test is further subsegmented into Venereal disease research laboratory (VDRL) test, Fluorescent treponemal antibody absorption (FTA-ABS), Rapid plasma reagin (RPR), Treponema pallidum particle agglutination assay (TPPA), and others. Imaging tests is further sub-segmented into Computed Tomography (CT), X-rays, Magnetic resonance imaging (MRI), and others.

On the basis of treatments, the market has been segmented into antibiotic penicillin, antibiotics probenecid, ceftriaxone and others. Antibiotic penicillin is further sub-segmented into Injection and oral.On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.

Global Neurosyphilis Market- Regional Analysis

Considering the global scenario of the market, the Americas are holding the largest market for Neurosyphilis. The Americas mainly include North America and Latin America, out of which North America is holding majority of market share of this region.

US is the top revenue generating market in North America and is one of the important markets for global Neurosyphilis.

Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/4021

Major Points form TOC for Neurosyphilis Market Research Report – Forecast to 2023

1. Introduction

1.1 Definition

1.2 Scope of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

..Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurosyphilis Market - Growth Drivers - Abbott, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc. , Novartis AG , Pfizer Inc.,Sanofi | Strategic Analysis 2023 here

News-ID: 1273482 • Views:

More Releases from Market Research Future

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical
Laboratory Equipment Market Projected to Reach USD 102.11 Billion with 7.66% CAGR by 2032
Laboratory Equipment Market Projected to Reach USD 102.11 Billion with 7.66% CAG …
Market Overview: The Laboratory Equipment Market is estimated to be valued at USD 49.6 billion in 2024 and is projected to reach USD 78.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031. The market growth is primarily driven by the rising demand for advanced research tools in pharmaceuticals, biotechnology, clinical diagnostics, and academic institutes. Increasing investment in R&D activities, coupled with technological
Medical Second Opinion Market Set to Grow to USD 21.36 Billion at a 14.30% CAGR by 2034
Medical Second Opinion Market Set to Grow to USD 21.36 Billion at a 14.30% CAGR …
Market Overview: The Medical Second Opinion Market is estimated to grow significantly from 2024 to 2031, driven by the rising need for accurate diagnosis, treatment validation, and better patient care. A second opinion helps patients make more informed healthcare decisions, particularly in cases of complex surgeries, rare diseases, or chronic illnesses. With increasing awareness among patients about medical errors and the importance of exploring alternative treatments, the demand for medical second
Penicillin Drug Market Forecasted to Surpass USD 14.36 Billion at a 3.64% CAGR by 2034
Penicillin Drug Market Forecasted to Surpass USD 14.36 Billion at a 3.64% CAGR b …
Market Overview: The Penicillin Drug Market is estimated to be valued significantly in 2024 and is projected to grow steadily, reaching a substantial valuation by 2031. This growth is driven by the continued reliance on penicillin as a frontline antibiotic and its wide therapeutic applications in bacterial infection management. Penicillin remains one of the most widely prescribed antibiotics globally, with demand sustained by rising bacterial infection prevalence, increasing healthcare expenditure, and

All 5 Releases


More Releases for Neurosyphilis

Global Neurosyphilis Market Insights, Forecast to 2029
Neurosyphilis Market Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%-40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection. Market
Neurosyphilis Market Sluggish Growth Rate Foreseen by 2021-2027 with Covid-19 Im …
This Neurosyphilis market report additionally offers further information concerning the COVID-19 crisis and scenario within the current market and sectors. Even if we won't forestall dangerous viruses from spreading, we must always build plans to mitigate their effects on the setting. The continued burst had large financial impacts around the nation, and it does not seem that any country is untouched. This can have so much implications for not solely
Global Neurosyphilis market: Which application segment will hold lion’s share? …
 QY Research has recently published a new report, titled Global Neurosyphilis Market Size, Status and Forecast 2021-2027 The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurosyphilis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurosyphilis market. The report offers an overview of
Neurosyphilis Market 2023 Top Key Players are Abbott, Bayer AG, Eli Lilly and Co …
Namely Neurosyphilis Market Report has Been Published by Market Research Future Which Covers All the Geographical Locations with Demand, Trend Analysis with near about Forecasted results and Also Covers the Market Expectations. Market Overview: Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual who have untreated syphilis for long period of time. This is mainly caused due to bacteria called Treponema pallidum. This is the
Neurosyphilis Market expected to grow at the CAGR of ~3.9% with Abbott, Bayer AG …
Market Overview: Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual who have untreated syphilis for long period of time. This is mainly caused due to bacteria called Treponema pallidum. This is the bacteria which causes syphilis. After getting infected with syphilis for the first time, there are chances of neurosyphilis after 10-20 years later. The major symptoms of neurosyphilis are blindness, abnormal walk,
Neurosyphilis Market is expected to grow at a CAGR over 3.9 % from 2017 to 2023 …
The “Global Neurosyphilis Market Research Report 2018” is the latest comprehensive analysis document assists the reader to build effective business strategies. This report provides an in-depth insight covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis. Global Neurosyphilis Market -Scenario Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual who have untreated syphilis for long period of time. This is